Oxcarbazepine Tablet, Film Coated
Product Images NDC 31722-023

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 31722-023). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Oxcarbazepinetabfig1 (Oxcarbazepinetabfig1)

A line graph depicting the exit rate over time from Day 2 to Day 11 for a clinical trial comparing Oxcarbazepine (solid line) and placebo (dashed line). The y-axis represents exit rate from 0.0 to 1.0, and the graph shows a higher exit rate for placebo compared to Oxcarbazepine. A log-rank test with p-value 0.0001 is noted.*

FDA Label Image

Oxcarbazepinetabfig2 (Oxcarbazepinetabfig2)

A line graph showing seizure rate over days from first dose to first seizure comparing Oxcarbazepine treatment group (solid line) and placebo group (dotted line). The graph includes a log-rank test with a p-value of 0.046, indicating a statistical analysis of seizure occurrence over time.*

FDA Label Image

Oxcarbazepinetabfig3 (Oxcarbazepinetabfig3)

A Kaplan-Meier survival curve chart showing exit rate over time (in days) for two treatment groups labeled HIGH (solid line) and LOW (dotted line). The y-axis represents the exit rate from 0.0 to 1.0, and the x-axis represents time to exit in days from 0 to 130. The chart includes a log-rank test p-value of 0.0001 indicating statistical comparison between groups.*

FDA Label Image

Oxcarbazepinetabfig4 (Oxcarbazepinetabfig4)

A Kaplan-Meier survival curve chart depicting exit rate over time in days for two treatment groups labeled as HIGH and LOW. The chart includes a log-rank test with a p-value of 0.0001, showing a higher exit rate for the LOW group compared to the HIGH group over approximately 130 days.*

FDA Label Image

Oxcarbazepinetabstruct (Oxcarbazepinetabstruct)

Chemical structure of oxcarbazepine, showing fused rings including a benzene and a seven-membered ring with a ketone and amide functional groups attached.*

FDA Label Image

Oxcarbazipinetab150mgcontlabel (Oxcarbazipinetab150mgcartonlabel)

Oxcarbazepine Tablets USP 150 mg film-coated tablets packaging label from Camber Pharmaceuticals, Inc. The label indicates the NDC number 31722-023-01 and specifies a package quantity of 100 tablets. It includes storage instructions, dosage form details, and a medication guide contact number. The product is marked as prescription only (Rx only).*

FDA Label Image

Oxcarbazipinetab300mgcontlabel (Oxcarbazipinetab300mgcartonlabel)

Label for Oxcarbazepine Tablets, USP 300 mg film-coated oral tablets by Camber Pharmaceuticals, Inc. The label includes the NDC 31722-024-01, dosage instructions to see the package insert, storage conditions, and a count of 100 tablets. It features a barcode and contact information for the manufacturer.*

FDA Label Image

Oxcarbazipinetab600mgcontlabel (Oxcarbazipinetab600mgcartonlabel)

Label for Oxcarbazepine Tablets, USP 600 mg film-coated oral tablets by Camber Pharmaceuticals, Inc. The label indicates 100 tablets per container and includes storage instructions, pharmacist dispensing guidance, and manufacturer information including Annora Pharma Pvt. Ltd. and Camber Pharmaceuticals, Inc. A barcode and a designated varnish area for batch coding are also visible.*

FDA Label Image

Oxcarbazipinetabcamberlogo1 (Oxcarbazipinetabcamberlogo1)

FDA Label Image

Oxcarbazipinetabcamberlogo2 (Oxcarbazipinetabcamberlogo2)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.